SKB BIO(06990) - 2025 Q4 - Earnings Call Transcript

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:06990) H2 2025 Earnings call March 23, 2026 08:00 AM ET Company ParticipantsDing Nanchao - Deputy General Manager and Chief Marketing OfficerGe Junyou - President and CEOJinbo Zhang - Director of the Analytical DepartmentMatthew Culley - Portfolio ManagerWei Chen - Deputy General Manager and VP of Molecule R&DXiangyang Tan - Chief Scientific OfficerXiao Ping Jin - Chief Medical OfficerZe Jian Zhou - CFOConference Call ParticipantsShen Ziyi - Equity Research Anal ...